We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
Cap. Flow
-$915M
Cap. Flow %
-1.97%
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$170M
2
T icon
AT&T
T
+$142M
3
MSFT icon
Microsoft
MSFT
+$136M
4
XLNX
Xilinx Inc
XLNX
+$110M
5
AMZN icon
Amazon
AMZN
+$86.9M

Sector Composition

Rank Sector Weight
1 Technology 31.53%
2 Consumer Discretionary 13.24%
3 Communication Services 9.89%
4 Healthcare 9.39%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSR
1976
DELISTED
Whitestone REIT
WSR
$134K ﹤0.01%
10,234
-1,257
-11% -$14.4K
BTRS
1977
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$134K ﹤0.01%
17,828
+3,427
+24% +$22.2K
TRTX
1978
TPG RE Finance Trust
TRTX
$666M
$133K ﹤0.01%
11,259
-1,861
-14% -$22.7K
FSP
1979
Franklin Street Properties
FSP
$44.8M
$132K ﹤0.01%
22,359
-2,816
-11% -$16.3K
GPMT
1980
Granite Point Mortgage Trust
GPMT
$63.7M
$132K ﹤0.01%
11,897
-1,470
-11% -$16.8K
YMAB
1981
DELISTED
Y-mAbs Therapeutics
YMAB
$132K ﹤0.01%
11,069
-2,710
-20% -$27.8K
BRY
1982
DELISTED
Berry Corp
BRY
$131K ﹤0.01%
12,646
-2,089
-14% -$19.8K
SRNE
1983
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$131K ﹤0.01%
56,014
-9,251
-14% -$28.9K
ACEL icon
1984
Accel Entertainment
ACEL
$979M
$129K ﹤0.01%
10,562
-1,746
-14% -$22.6K
ECVT icon
1985
Ecovyst
ECVT
$1.36B
$129K ﹤0.01%
11,142
-79
-0.7% -$829
ATRS
1986
DELISTED
Antares Pharma, Inc.
ATRS
$129K ﹤0.01%
31,299
-5,169
-14% -$18.8K
QNST icon
1987
QuinStreet
QNST
$870M
$128K ﹤0.01%
11,165
-1,371
-11% -$18.4K
RKT icon
1988
Rocket Companies
RKT
$36.9B
$128K ﹤0.01%
11,501
-119
-1% -$1.47K
CHS
1989
DELISTED
Chicos FAS, Inc.
CHS
$128K ﹤0.01%
26,829
-3,298
-11% -$15.4K
DCPH
1990
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$125K ﹤0.01%
13,515
-3,318
-20% -$28.2K
PRVB
1991
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$125K ﹤0.01%
16,957
-4,080
-19% -$24.4K
HTBK
1992
DELISTED
Heritage Commerce
HTBK
$124K ﹤0.01%
10,960
-1,818
-14% -$21.8K
ZNGA
1993
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$124K ﹤0.01%
+13,422
New +$118K
GERN icon
1994
Geron
GERN
$911M
$123K ﹤0.01%
90,464
-21,452
-19% -$23.9K
EGIO
1995
DELISTED
Edgio, Inc. Common Stock
EGIO
$123K ﹤0.01%
586
-97
-14% -$16.2K
RDUS
1996
DELISTED
Radius Health, Inc.
RDUS
$121K ﹤0.01%
13,682
-3,211
-19% -$24.3K
EWTX icon
1997
Edgewise Therapeutics
EWTX
$4.39B
$120K ﹤0.01%
12,378
-3,015
-20% -$38.8K
WW
1998
DELISTED
WW International
WW
$120K ﹤0.01%
11,728
-1,447
-11% -$17K
BFLY icon
1999
Butterfly Network
BFLY
$1.72B
$119K ﹤0.01%
25,069
-2,209
-8% -$12.1K
AERI
2000
DELISTED
Aerie Pharmaceuticals
AERI
$119K ﹤0.01%
12,946
-2,971
-19% -$22.9K

Similar funds

ProShare Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
  • ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
  • ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
  • ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
  • ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
  • ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
  • ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.